Acadia Pharmaceuticals Inc.
$4.96B- Market cap
- $4.83B
- Debt
- +$306.51M
- Cash
- −$177.70M
Capital structure 94% equity / 6% debt · EV / Revenue 4.63x · EV / EBITDA 32.90x
Quick read
Fair value engine
Each company valued on the other's multiple, then compared with the market price.
ACAD · current priceP/E 12.18x
$28.02Latest market snapshot
Implied fair value · at LVS's multiple
$43.4355.0% above market
2.30 ACAD EPS (TTM)×18.88x LVS P/E=$43.43
Market $28.02Implied $43.43
LVS · current priceP/E 18.88x
$44.37Latest market snapshot
Implied fair value · at ACAD's multiple
$28.6335.5% below market
2.35 LVS EPS (TTM)×12.18x ACAD P/E=$28.63
Market $44.37Implied $28.63